Multiprofile Hospital For Active Treatment - Shumen AD — Clinical Trial Site

13 Registered trials

4 Currently recruiting

Organisation

Multiprofile Hospital For Active Treatment - Shumen AD

Location

Shumen, Bulgaria

Identifier

ORG-100042513

Address

Ulitsa Vasil Aprilov 63, 9705, Bulgaria

Departments

Department - Orthopaedics and Traumatology
Department of Neurology Diseases
Department of Urology
Department Orthopaedics and Traumatology
First Internal Department
Pneumology
Pneumology and phthisiology
Second Internal Department
Urology

Clinical trials at this site (13)

Search interface

BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 µg]) vs Single Inhaler ICS/LABA (200/… Pending

2025-524289-56-00 Asthma 6
A Phase 3 Single-arm Study of UGN-104 for the Treatment of LG-UTUC Recruiting

2024-519343-15-00 Low-grade Upper Tract Urothelial Cancer 5 2025-10-08
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with P… Recruiting

2024-514617-35-00 Progressive forms of Multiple Sclerosis 4 2021-12-20
A study to test if SRSD107 prevents venous thromboembolism events and how safe it is Recruiting

2024-519688-16-00 venous thromboembolism 4 2025-08-07
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD Ended

2025-523020-50-00 Chronic Obstructive Pulmonary Disease 4 2026-03-04
A Phase 3 Single-arm Study of UGN-103 for the Treatment of LG IR NMIBC. Ended

2023-507261-25-00 Nonmuscle Invasive Bladder Cancer 5 2024-10-03
A Phase 3 Single-Arm Study of UGN-102 for Treatment of LG IR NMIBC Ended

2023-506680-34-00 Non-Muscle Invasive Bladder Cancer 5 2022-03-24
Multi-center study of a fentanyl nasal spray compared with placebo nasal spray for postoperative pain management. Ended

2024-519625-38-00 Postoperative pain relief 5 2024-04-14
A Phase 3 study to assess efficacy and safety of oral tebipenem compared to IV imipenem-cilastatin in adults with cUTI/AP Ended

2023-503785-22-00 complicated urinary tract infection (cUTI) or acute pye 5 2024-03-25
A 12-week double-blind, multicentre, randomised, active-controlled, 2-arm, parallel-group clinical trial to evaluate the safety of CHF5993 p… Ended

2023-503333-22-00 Moderate to severe controlled asthma according to Step 5 2024-01-15
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended

2022-502234-70-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-07-14
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24